leflunomide has been researched along with 6-ketoprostaglandin f1 alpha in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamilton, LC; Vojnovic, I; Warner, TD | 1 |
| Archer, TM; Mackin, AJ; Thomason, JM; Wills, RW | 1 |
1 trial(s) available for leflunomide and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Effects of immunosuppressive agents on the hemostatic system in normal dogs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Azathioprine; Blood Coagulation; Blood Platelets; Creatinine; Cross-Over Studies; Cyclosporine; Dogs; Female; Hemostasis; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Mycophenolic Acid; Platelet Aggregation; Platelet Count; Prednisone; Thromboxane B2 | 2018 |
1 other study(ies) available for leflunomide and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
A771726, the active metabolite of leflunomide, directly inhibits the activity of cyclo-oxygenase-2 in vitro and in vivo in a substrate-sensitive manner.
Topics: 6-Ketoprostaglandin F1 alpha; Aniline Compounds; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Blotting, Western; Cell Survival; Crotonates; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme Induction; Enzyme Inhibitors; Humans; Hydroxybutyrates; In Vitro Techniques; Isoenzymes; Isoxazoles; Leflunomide; Macrophages; Male; Membrane Proteins; Mice; Nitric Oxide; Nitric Oxide Synthase; Nitriles; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Substrate Specificity; Toluidines | 1999 |